Latest news
March 10, 2017
Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case
March 7, 2017
Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics
March 2, 2017
Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test
February 21, 2017
Debiopharm International SA Appeals to the Supreme Court regarding Nippon Kayaku Co., Ltd. case
January 23, 2017
Debiopharm Investment strengthens its presence in the renewable energy sector
January 11, 2017
GenePOC to Announce CE Marking of its revogene™ Instrument and its Second Test, CDiff
January 10, 2017
Debiopharm International SA Announces positive Phase 2 Clinical Trial with Debio 1450 in ABSSSI patients
Stay informed
Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.